A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study

- Jee, Adelle S., Stewart, Iain, Moodley, Yuben P., Bleasel, Jane F., Macansh, Sacha, Nikpour, Mandana, Sahhar, Joanne, Corte, Tamera J., Australian Scleroderma Cohort Study, Australian Scleroderma Interest Group, Australian Idiopathic Pulmonary Fibrosis Registry, and associated investigators,, Youssef, Peter, Adelstein, Stephen, Lai, Donna, Hua, Sheng, Stevens, Wendy, Proudman, Susanna, Ngian, Gene-Siew, Glaspole, Ian N.

Biomarker signatures for progressive idiopathic pulmonary fibrosis

- Clynick, Britt, Corte, Tamera J., Reynolds, Paul N., Chapman, Sally, Zappala, Christopher, Keir, Gregory J., Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samatha, Goh, Nicole S., De Jong, Emma, Cha, Lilian, Jo, Helen E., Leigh, Lucy, Oldmeadow, Christopher, Oldmeadow, C, Walters, EH, Jenkins, RG, Moodley, Y, Stewart, Iain, Glaspole, Ian N., Grainge, Christopher, Maher, Toby M., Navaratnam, Vidya, Hubbard, Richard, Hopkins, Peter M. A.

Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis

- Clynick, Britt, Jo, Helen E., Keir, Gregory J., Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samantha, Goh, Nicole S., Baltic, Svetlana, Rya, Marisa, Tan, Dino B. A., Moodley, Yuben P., Corte, Tamera J., Glaspole, Ian N., Grainge, Christopher, Hopkins, Peter M. A., Reynolds, Paul N., Chapman, Sally, Walters, E. Haydn, Zappala, Christopher